SUPRIYANSESupriya Lifescience LimitedLowNeutral
Announced Wed, 21 May · 17:17 IST

Supriya Lifescience Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SUPRIYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Supriya Lifescience has scheduled an earnings call for Wednesday, May 28, 2025 at 11:00 AM IST to discuss its operational and financial performance for Q4 and the full financial year ended March 31, 2025. The call will be hosted by Dr. Satish Wagh (Executive Chairman), Dr. Saloni Wagh (Managing Director), and Mr. Krishna Raghunathan (Chief Financial Officer). Investors can join via a Diamond Pass registration link or through dial-in numbers provided for India, Hong Kong, Singapore, USA, and UK. An investor presentation will be shared with the stock exchanges separately. The filing was made under SEBI Listing Regulations to keep the exchanges informed.

Likely market impact

This is a routine pre-results intimation and does not directly affect the stock price. Investors should watch for the actual Q4/FY25 earnings numbers and management guidance on May 28, which could drive short-term sentiment.